Predicting low disease activity and remission using early treatment response to anti-TNF therapy in patients with rheumatoid arthritis: Exploratory analyses from the TEMPO trial

OBJECTIVE: To derive and validate decision trees to categorize rheumatoid arthritis (RA) patients 12 weeks after starting etanercept with or without methotrexate into three groups: patients predicted to achieve low disease activity (LDA) at 1 year; patients predicted to not achieve LDA at 1 year; an...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Curtis, Jeffrey R., Yang, Shuo, Chen, Lang, Park, Grace S., Bitman, Bojena, Wang, Brian, Navarro-Millan, Iris, Kavanaugh, Arthur
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3698970/
https://ncbi.nlm.nih.gov/pubmed/21998118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2011.153551
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires